학술논문

Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study
Document Type
Journal
Source
JOURNAL OF NEUROSURGERY-PEDIATRICS; JUN 2023, 31 6, p624-p632, 9p.
Subject
Language
English
ISSN
19330715